Summit Therapeutics is celebrating National Cancer Survivors Day! #NCSD2024 #NationalCancerSurvivorsDay #NationalCancerSurvivorsMonth #CancerSurvivor #CelebrateSurvivorship #ResearchSavesLives #ivonescimab #LungCancer #NSCLC #oncology #cancerinnnovation #patientsfirst #patientfriendly #ASCO24 Summit booth #14039
Summit Therapeutics, Inc.’s Post
More Relevant Posts
-
This new #Oncology study investigates drug therapy patterns in patients with breast cancer using TriNetX #RealWorldData. Read the abstract here: https://ow.ly/4Bnw30sFbhl #RealWorldEvidece #OncologyResearch
To view or add a comment, sign in
-
Ending Cancer drug shortages in rural areas - American Society of Clinical Oncology (ASCO) https://lnkd.in/dWtmDXXe #ClinicalOncology #ASCO #Cancer #CancerAdvocacy #CancerAwareness #OncoDaily #Oncology
To view or add a comment, sign in
-
Discover the potential of antibody-drug conjugates in cancer treatment. Our list of the current approved ADC drugs is now available as a PDF download. Get your copy today and stay informed! 🤩📑 #ADCs #ADCPipeline #LARVOLCLIN #Oncology #CancerResearch
To view or add a comment, sign in
-
Who should get LDCT screening for lung cancer? How do you calculate pack-years? Our review of USPSTF guidelines https://lnkd.in/gWuyHSWd #LungCancerScreening #CancerPrevention #Healthcare #EarlyDetection Lungcancer #oncology
To view or add a comment, sign in
-
Oxaliplatin injection, a key player in the fight against colorectal cancer, continues to make strides in improving treatment outcomes. #Oncology #MedicalInnovation #CancerResearch #HealthcareHeroes #Oncology together! 💙 #MedicalInnovation #CancerResearch
To view or add a comment, sign in
-
Discover the potential of antibody-drug conjugates. Our latest ADC pipeline is now available for download. 🤩📑 Get your copy today and stay informed! #ADCs #ADCPipeline #LARVOLCLIN #Oncology #CancerResearch
To view or add a comment, sign in
-
Are you up-to-date with the latest data on metastatic castration-resistant prostate cancer (mCRPC)? Review expert-led highlights from #ASCO24 on Medthority https://ow.ly/Q1v250SqPwn #Oncology #MedEd #ProstateCancer #OncologyResearch
To view or add a comment, sign in
-
Great discussion with our key experts during the AstraZeneca symposium on "Exploring Advanced Paths: Strategic Approach in Manager HER2-Positive Breast Cancer Antibodies", only at #APBCS2024! #APBCS2024 #BreastCancer #faculty #speaker #panelist #breastoncology #registration #SABCS #Bali #indonesia #BaliSummit #BreastCancer #oncology #treatment #healthcare #cancercare #oncologyresearch #registration #CPE #CME
To view or add a comment, sign in
-
Founder Director @ Mestastop | Metastasis Research, Drug Discovery, Repurposing & Predictive Diagnostics
Watch this space for more as we develop and progress MS-AP-031 to delay metastasis in primary tumour patients in an adjuvant, neo-adjuvant setting.
A promise we made and delivered! Introducing MS-AP-031 It is proven to delay #metastasis in #colorectalcancer patients! ✅ Check 👇 our case-study Follow Mestastop® Solutions to get more exciting news in the fight against cancer #nononcologydrugs #oncology #drugrepurposing #drugdevelopment #cancerdrug #cancertreatment #cancerresearch
To view or add a comment, sign in
-
🔥 Presidential Highlight from ESMO 2024! Dr Sheela Rao and Prof Dr Eric Van Cutsem present key findings from a pivotal study on metastatic anal cancer, exploring the addition of immunotherapy to standard chemotherapy: - PFS Improvement: The combination therapy showed a significant increase in PFS. - OS Trend: Early data indicate a possible six-month OS benefit. - Safety: The combination was well tolerated, with manageable immune-related side effects. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #GICancer #Oncology #AnalCancer #ClinicalTrials #CancerResearch
To view or add a comment, sign in
19,333 followers